RNA-seq analysis of the human SC1 lymphoma cell line after bryostatin treatment
RNA-seq analysis was performed on a CD72 antigen-low human lymphoma cell line (SC1) to examine gene expression changes after bryostatin treatment compared to DMSO Overall design: RNA-seq profiling of total RNA transcript levels in human SC1 lymphoma cell line treated with bryostatin or DMSO (vehicle), with three samples per condition.